Background The optimal time interval between the end of neoadjuvant systemic therapy
(NST) and breast surgery is still unclear. It is not known if a delay in surgery might influence …

Background The impact of length of time to surgery (TTS) on oncologic outcomes following
neoadjuvant chemotherapy (NAC) in breast cancer patients is unclear. We investigated the …

Background Neoadjuvant chemotherapy (NACT) is a cornerstone in managing breast
cancer. There is no defined consensus on the optimal time between NACT and surgery. We …

Background No studies have examined the impact of the interval from conclusion of
neoadjuvant chemotherapy to surgery in breast cancer patients. This study was undertaken …

Background: There is a paucity of literature examining the impact of timing of surgery after
neoadjuvant chemotherapy. Objective: This study aimed to analyze the impact of the time …

Background Administration of chemotherapy before breast surgery has the potential to
reduce the risk of distant recurrence by targeting micrometastasis as well as allowing a more …

Purpose It is suspected that delayed surgery after neoadjuvant chemotherapy (NACT) leads
to a worse outcome in breast cancer patients. We therefore evaluated possible influencing …

Background Neoadjuvant chemotherapy (NAC) is increasingly used in the treatment of
breast cancer. The time interval from last dose of cytotoxic chemotherapy to surgery (TTS) …

Abstract Background/Objective Delays in times to surgery, chemotherapy, and radiotherapy
impair survival in breast cancer patients. Neoadjuvant chemotherapy (NAC) confers …

Background Although neoadjuvant chemotherapy (NCT) is standard therapy for locally
advanced breast cancer, it remains controversial for early-stage disease due to concerns …